VIVE News and Press, Viveve Medical Inc. From 09/07/21

ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright 23 rd Annual Global Investment Conference...

Viveve Medical, Inc. (VIVE) Q2 2021 Earnings Conference Call August 12, 2021 05:00 PM ET Company Participants Jeannie Swindle - Senior Director of Corporate Communications Scott Durbin - Chief Executive Officer Jim Robbins - Senior Vice President of Finance and Administration Conference Call ...

Total revenue of $1.7M reported for Q2 Reported sales of approximately 3,500 consumable treatment tips - a 42% unit increase quarter-over-quarter Pivotal SUI PURSUIT trial enrollment on-track for completion in early Q4 Potential long-term reimbursement pathway established with...

ENGLEWOOD, CO / ACCESSWIRE / August 5, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its second quarter 2021 financial results and provide a corporate update after the close of the U.S. financia...

ENGLEWOOD, CO / ACCESSWIRE / August 3, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Canadian Intellectual Property Office (CIPO) recently issued Canadian Patent No. 3028905 for Viveve's dual-energy techno...

New code approved by American Medical Association and supported by key medical societies Long-term pathway for potential reimbursement now established for Company's dual-energy noninvasive treatment for urethral hypermobility to improve stress urinary incontinence in women ENGLEWOOD...

ENGLEWOOD, CO / ACCESSWIRE / July 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the Ladenburg Thalmann Healthcare Conference, July 13 - 14, 2021. M...

ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and Trademark Office (USPTO) recently issued U.S. Patent No. 10,980,596 for Viveve's dual-energy tec...

Viveve Medical, Inc. (VIVE) Q1 2021 Results Conference Call May 13, 2021 05:00 AM ET Company Participants Jeannie Swindle - Senior Director of Corporate Communications Scott Durbin - Chief Executive Officer Jim Robbins - Senior Vice President of Finance and Administration Conference Call Part...

Viveve Medical (VIVE): Q1 GAAP EPS of -$0.80 misses by $0.29.Revenue of $1.45M (+11.5% Y/Y) beats by $0.12M.Shares +0.8%.Press Release For further details see: Viveve Medical EPS misses by $0.29, beats on revenue